my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
24-11-2005: Exiqon A/S announced that it has won the Ernst & Young Entrepreneur Of The Year award in the category Biotech 2005. The prestigious award is created to identify and acknowledge the most successful and entrepreneurial Danish companies.
A minimum growth of 15% in sales as well as growth in staff is among the key nomination criteria. An impressive turnaround of the company in just 2 years, a successful business strategy and break-through research results were some of the points emphasized by the jury when Exiqon was named the best biotech company in Ernst & Young Entrepreneur of the Year competition.
Watchlist
This is where you can add this news to your personal favourites
Michael Kallelis to manage Exiqon's new us facility
Exiqon A/S announced the appointment of Michael Kallelis as President and General Manager of Exiqon's new US operations. Mr. Kallelis will have the overall responsibility for launching and operating Exiqon's US office to be located in the Boston area. A key focus of the new facility will be ... more
Exiqon A/S wins prestigious Ernst & Young Entrepreneur of the Year Award
Exiqon A/S announced that it has won the Ernst & Young Entrepreneur Of The Year award in the category Biotech 2005. The prestigious award is created to identify and acknowledge the most successful and entrepreneurial Danish companies. A minimum growth of 15% in sales as well as growth in ... more
U.S. Genomics Licenses Locked Nucleic Acid (LNA(TM)) Chemistries from Exiqon
Woburn and Copenhagen. U.S. Genomics and Exiqon have entered into a worldwide license agreement to incorporate Exiqon's Locked Nucleic Acid (LNA(TM)) chemistries into reagent kits for the U.S. Genomics Trilogy(TM) platform. Introduced into the market early last month, the Trilogy(TM) platfo ... more
Enabling life science researchers to make groundbreaking discoveries Exiqon combines leading-edge scientific expertise in gene expression with our proprietary LNA™ technology. Our products, services and scientific staff enable life science researchers to make groundbreaking discoveries. ... more
France Biotech presents the results of its tenth annual "Life Science Panorama 2011" survey
France Biotech in partnership with Ernst & Young, published for the 10th year running the 'Life Science Panorama', describing the industry's main trends for 2010/2011 in France and worldwide. This time, almost 200 French companies took part in the survey. The panorama highlights the maturit ... more
AC Immune SA, announced today that Ernst &Young awarded Prof. Andrea Pfeifer the Entrepreneur of the Year® 2009 Switzerland in the category Life Sciences/High-Tech. This intensive competition has been conducted annually in Switzerland since 1998 as part of Ernst & Young’s global program eva ... more
Aquapharm CEO wins Ernst & Young Scotland entrepreneur of the year award 2008
Dr. Andrew Mearns Spragg, founder and CEO of Aquapharm Biodiscovery, a Scotland based marine biotechnology company, has been announced as the winner of this year's Ernst & Young Scottish Entrepreneur of the year in healthcare. The awards recognize Dr. Mearns Spragg's entrepreneurial ambitio ... more
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
